Is Trillium Therapeutics Inc (TRIL) Stock a Great Value?

Tuesday, June 30, 2020 4:08 PM | InvestorsObserver Analysts

Trillium Therapeutics Inc (TRIL) stock is up 2279.41% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TRIL stock a score of 73 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 98. TRIL's rank also includes a long-term technical score of 89. The fundamental score for TRIL is 33. In addition to the average rating from Wall Street analysts, TRIL stock has a mean target price of 8.91. This means analysts expect the stock to rise 10.14% over the next 12 months.

Overall Score - 73
TRIL has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on TRIL!

What's Happening with TRIL Stock Today

Trillium Therapeutics Inc (TRIL) stock has risen 10.82% while the S&P 500 is up 0.59% as of 4:00 PM on Tuesday, Jun 30. TRIL is up $0.79 from the previous closing price of $7.30 on volume of 1,738,377 shares. Over the past year the S&P 500 has gained 3.60% while TRIL is up 2279.41%. TRIL earned $2.58 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.14.

Click Here to get the full Stock Score Report on Trillium Therapeutics Inc (TRIL) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

TSX Down 21 Points on Mixed Sectors

Sector Update: Consumer Stocks Extending Thursday Advance

Moderna Inc (MRNA) Stock: What's Next?

Related Companies